The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD

Kidney International

Volumn 51, Issue 6, 1997, Pages 1885-1892

  Douma, Caroline E ^a   De Waart, Dirk R ^b   Struijk, Dirk G ^b   Krediet, Raymond T ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; PERITONEUM; PERMEABILITY; PRIORITY JOURNAL;

EID: 0030979321     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.257     Document Type: Article

References (48)

1. NOLPH KD, GHODS AJ, VAN STONE J, BROWN PA: The effects of intraperitoneal vasodilators on peritoneal clearances. ASAIO Trans 22:586-594, 1976
2. NOLPH KD, GHODS A, BROWN PA, MILLER F, HARRIS P, PYLE K, POPOVICH R: Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology. ASAIO Trans 23:210-218, 1977
3. MILLER FN, JOSHUA IG, HARRIS PD, WIEGMAN DL, JAUCHEM JR: Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol 17:51-58, 1979
4. KREDIET RT, ZEMEL D, IMHOLZ ALT, STRUIJK DG: Impact of surface area and permeability on solute clearances. Perit Dial Int 14 (Suppl 3):S70-S77, 1994
5. GRUETTER CA, GRUETTER DY, LYON JE, KADOWITZ PJ, IGNARRO LJ: Relationship between cyclic guanosine 3,5-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219:181-186, 1981
6. KOSAKA H, IMAIZUMI K, IMAI K, TYUMA I: Stoichiometry of the reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta 5811: 184-188, 1979
7. HIBBS JB JR, WESTENFELDER C, TAINTOR R, VAVRIN Z, KABLITZ C, BARANOWSKI RL, WARD JH, MENLOVE RL, MCMURRY MP, KUSHNER JP, SAMLOWSKI WE: Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867-877, 1992
8. KELM M, SCHRADER J: Control of coronary vascular tone by nitric oxide. Circ Res 66:1561-1575, 1990
9. DOUMA CE, DE WAART DR, ZEMEL D, IMHOLZ ALT, STRUIJK DG, KREDIET RT: Nitrate in stable CAPD patients and during peritonitis. Adv Perit Dial 11:36-40, 1995
10. KREDIET RT, ZUYDERHOUDT FMJ, BOESCHOTEN EW, ARISZ L: Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 17:43-52, 1987
11. ZEMEL D, KOOMEN GCM, HART AAM, TEN BERGE RJM, STRUIJK DG, KREDIET RT: Relationship of TNFα, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 122:686-696, 1993
12. PANNEKEET MM, IMHOLZ ALT, STRUIJK DG, KOOMEN GCM, LANGEDIJK MJ, SCHOUTEN N, DE WAARD DR, HIRALALL J, KREDIET RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48:866-875, 1995
13. KREDIET RT, STRUIJK DG, KOOMEN GCM, ARISZ L: Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 37:662-667, 1991
14. RENCK H, LJUNGSTRÖM HG, HEDIN H, RICHTER W: Prevention of dextran induced anaphylactic reaction by hapteen inhibition. Acta Chir Scan 149:355-360, 1983
15. NOLPH KD, POPOVICH RP, GHODS AJ, TWARDOWSKI Z: Determinants of low clearances of small solutes during peritoneal dialysis. Kidney Int 13:117-123, 1978
16. GRZEGORZEWSKA AE, MOORE HL, NOLPH KD, CHEN TW: Ultrafiltration and effective peritoneal blood flow during peritoneal dialysis in the rat. Kidney Int 39:608-617, 1991
17. GRZEGORZEWSKA AE, ANTONIEWICZ K: An indirect estimation of effective peritoneal capillary blood flow in peritoneally dialyzed uremic patients. Perit Dial Int 13:S39-S40, 1992
18. MCGUIRE EAH, HELDERMAN JH, TOBIN JD, ANDRES R BERMAN M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
19. 2, pH and lactate from arterialized venous blood. J Appl Physiol 32:134-137, 1972
20. KOOMEN GCM, KREDIET RT, LEEGWATER ACJ, STRUIJK DG, ARISZ L, HOEK FJ: A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. Adv Perit Dial 7:10-14, 1991
21. THOMAS CMG, VAN DEN BERG RJ, DE KONING GANS HJ, LEQUIN RM: Radioimmunoassays for prostaglandins.II. Measurement of prostaglandin E2 and the 13,14-dihydro-15-keto metabolites of the E and F series. Description of a reliable technique with a universal applicability. Prostaglandins 15:849-855, 1978
22. WANIEWSKI J, WERYNSKI A, HEIMBÜRGER O, LINDHOLM B: Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 9:129-141, 1991
23. WANIEWSKI J, HEIMBÜRGER O, WERYNSKI A, LINDHOLM B: Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 7:50-56, 1992
24. GARRED LJ, CANAUD B, FARRELL PC: A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis. ASAIO J 6:131-137, 1983
25. ZEMEL D, KREDIET RT, KOOMEN GCM, STRUIJK DG, ARISZ L: Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 11:217-233, 1991
26. IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L, KREDIET RT: Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 43:1339-1346, 1993
27. REDDINGIUS RE, SCHRÖDER CH, DAHA MR, WILLEMS HL, KOSTER AM, MONNENS LAH: Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 15:49-53, 1995
28. KREDIET RT: Fluid absorption in the peritoneum-It is less simple than you thought. Nephrol Dial Transplant 9:341-343, 1994
29. CANAUD B, LIENDO-LIENDO C, CLARET G, MION H, MION C: Etude "in situ" de la cinétique de l'ultrafiltration en course de dialyse péritonéale avec périodes de diffusion prolongée. Néphrologie 1:126-130, 1980
30. RUBIN J, NOLPH KD, POPOVICH RP, MONCRIEF JW, PROWANT B: Drainage volumes during continuous ambulatory peritoneal dialysis. ASAIO J 2:54-60, 1979
31. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, LINDHOLM B: A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 41:1320-1332, 1992
32. RIPPE B, STELIN G: Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 35:1234-1244, 1989
33. IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L, KREDIET RT: Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int 44:1078-1085, 1993
34. KREDIET RT, ZEMEL D, IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L: Indices of peritoneal permeability and surface area. Perit Dial Int 13:S31-S34, 1993
35. KOOPMANS JG, HO-DAC-PANNEKEET MM, STRUIJK DG, KREDIET RT: Restriction coefficients of low molecular weight solutes and macromolecules during CAPD. (abstract) Nephrol Dial Transplant 11:A255, 1996
36. GRZEGORZEWSKA AE, ANTONIEWICZ K: Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs. Adv Perit Dial 11:28-32, 1995
37. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide? Clin Nephrol 45:295-302, 1996
38. PIETRZAK I, HIRSZEL P, SHOSTAK A, WELCH PG, LEE RE, MAHER JF: Splanchnic volume, not flow rate, determines peritoneal permeability. ASAIO Trans 35:583-587, 1989
39. FOX J, GALEY F, WAYLAND H: Action of histamine on the mesenteric microvasculature. Microvasc Res 19:108-126, 1980
40. MILLER FN, JOSHUA IG, ANDERSON GL: Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy. Microvasc Res 24:56-67, 1982
41. ADDICKS K, ARNHOLD S, FASCHING P, HOFFMANN CH, BLOCH W: Nitric oxide mediates microvascular permeability in the isolated perfused rat mesentery? Agents Actions 45(Suppl):139-144, 1995
42. MONCADA S, HIGGS A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
43. STEINHAUER HB, SCHOLLMEYER P: Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 29:584-590, 1986
44. MILLER FN, NOLPH KD, HARRIS PD, RUBIN J, WIEGMAN DL, JOSHUA IG, TWARDOWSKI ZJ, GHODS AJ: Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 15:630-639, 1979
45. LEVIN TN, RIGDEN LB, NIELSEN LH, MOORE HL, TWARDOWSKI ZJ, KHANNA R, NOLPH KD: Maximum ultrafiltration rates during peritoneal dialysis in rats. Kidney Int 31:731-735, 1987
46. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, TRANAEUS A, LINDHOLM B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
47. STRUIJK DG, KREDIET RT, KOOMEN GCM, HOEK FJ, BOESCHOTEN EW, VAN DER REIJDEN HJ, ARISZ L: Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 59:213-220, 1991
48. MISTRY CD, GOKAL R, PEERS E, THE MIDAS STUDY GROUP: A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503, 1994